Investors who own more than 5% of a class must file a Schedule 13D or 13G. Every filing for N3144W105 since 12/18/2024, newest first.
| Filer | % of Class | Filed | |
|---|---|---|---|
| T. Rowe Price Investment Management, Inc. 13G/A Amendment 5 | 5.0% |
8/14/2026
Event 6/30/2026
|
|
| Price T Rowe Associates Inc /MD/ 13G/A Amendment 2 | 12.5% |
8/14/2026
Event 6/30/2026
|
|
|
American Century Investment Management, Inc.
13G
|
7.1% |
8/14/2026
Event 6/30/2026
|
|
| American Century Investment Management, Inc. | 7.1% | ||
| American Century Companies, Inc. | 7.1% | ||
| Stowers Institute for Medical Research | 7.1% | ||
|
FMR LLC
13G/A
Amendment 7
|
0% |
8/7/2026
Event 7/31/2026
|
|
| FMR LLC | 0% | ||
| Abigail P. Johnson | 0% | ||
|
FMR LLC
13G/A
Amendment 6
|
5.9% |
8/6/2026
Event 6/30/2026
|
|
| FMR LLC | 5.9% | ||
| Abigail P. Johnson | 5.9% | ||
| Oak Hill Advisors, L.P. 13D/A Amendment 5 | 10.5% |
4/21/2026
Event 4/17/2026
|
|
| Dimensional Fund Advisors LP 13G | 5.2% |
4/9/2026
Event 3/31/2026
|
|
| Vanguard Group Inc 13G/A Amendment 2 | 0% |
3/26/2026
Event 3/13/2026
|
|
| Price T Rowe Associates Inc /MD/ 13G/A Amendment 1 | 10.7% |
2/6/2026
Event 1/31/2026
|
|
| Price T Rowe Associates Inc /MD/ 13G/A Amendment 1 | 9.7% |
2/6/2026
Event 12/31/2025
|
|
|
FMR LLC
13G/A
Amendment 5
|
8.9% |
2/5/2026
Event 12/31/2025
|
|
| FMR LLC | 8.9% | ||
| Abigail P. Johnson | 8.9% | ||
| Price T Rowe Associates Inc /MD/ 13G | 7.9% |
11/14/2025
Event 9/30/2025
|
|
| Earnest Partners LLC 13G | 6.2% |
5/15/2025
Event 3/31/2025
|
|
| T. Rowe Price Investment Management, Inc. 13G/A Amendment 4 | 6.1% |
5/14/2025
Event 3/31/2025
|
|
| T. Rowe Price Investment Management, Inc. 13G/A Amendment 3 | 10.1% |
3/7/2025
Event 2/28/2025
|
|
| T. Rowe Price Investment Management, Inc. 13G/A Amendment 2 | 9.5% |
2/14/2025
Event 12/31/2024
|
|
| T. Rowe Price Investment Management, Inc. 13G/A Amendment 2 | 9.5% |
2/14/2025
Event 12/31/2024
|
|
| T. Rowe Price Investment Management, Inc. 13G/A Amendment 2 | 9.5% |
2/14/2025
Event 12/31/2024
|
|
| T. Rowe Price Investment Management, Inc. 13G/A Amendment 2 | 9.5% |
2/14/2025
Event 12/31/2024
|
|
| Price T Rowe Associates Inc /MD/ 13G/A Amendment 5 | 3.8% |
2/14/2025
Event 12/31/2024
|
|
| Price T Rowe Associates Inc /MD/ 13G/A Amendment 5 | 3.8% |
2/14/2025
Event 12/31/2024
|
|
| Price T Rowe Associates Inc /MD/ 13G/A Amendment 5 | 3.8% |
2/14/2025
Event 12/31/2024
|
|
|
FMR LLC
13G/A
Amendment 4
|
7.3% |
12/6/2024
Event 11/29/2024
|
|
| FMR LLC | 7.3% | ||
| Abigail P. Johnson | 7.3% |
| Period | Filings | Shares, Excl. Options | Value, Excl. Options |
|---|---|---|---|
| 2026 Q2 | 176 | 115 M | $1.79 B |
| 2026 Q1 | 189 | 115 M | $2.00 B |
| 2025 Q4 | 185 | 117 M | $1.57 B |
| 2025 Q3 | 174 | 112 M | $1.33 B |
| 2025 Q2 | 174 | 112 M | $956 M |
| 2025 Q1 | 200 | 109 M | $1.08 B |
| 2024 Q4 | 184 | 114 M | $1.42 B |
| 2024 Q3 | 177 | 119 M | $2.05 B |
| 2024 Q2 | 162 | 111 M | $2.53 B |
| 2024 Q1 | 139 | 106 M | $2.11 B |
| 2023 Q4 | 139 | 103 M | $1.63 B |
| 2023 Q3 | 136 | 98.1 M | $2.28 B |
| 2023 Q2 | 123 | 91.3 M | $1.62 B |
| 2023 Q1 | 134 | 90.5 M | $1.66 B |
| 2022 Q4 | 109 | 91.3 M | $1.65 B |
| 2022 Q3 | 104 | 95.9 M | $1.22 B |
| 2022 Q2 | 100 | 91.6 M | $1.05 B |
| 2022 Q1 | 92 | 86.2 M | $1.53 B |
| 2021 Q4 | 84 | 85.9 M | $1.23 B |
| 2021 Q3 | 2 | 52.2 k | $154 k |
| 2021 Q2 | 1 | 157 | $476.00 |
| 2021 Q1 | 1 | 157 | $557.00 |
| 2020 Q4 | 1 | 157 | $430.00 |
| 2020 Q3 | 1 | 157 | $242.00 |
| 2020 Q2 | 1 | 157 | $350.00 |
| 2020 Q1 | 1 | 157 | $407.00 |
| 2019 Q4 | 1 | 157 | $812.00 |
| 2019 Q3 | 1 | 157 | $746.00 |
| 2019 Q1 | 1 | 157 | $975.00 |
| 2018 Q4 | 1 | 157 | $820.00 |
| 2018 Q3 | 1 | 157 | $1.36 k |
| 2018 Q2 | 1 | 157 | $1.23 k |
| 2018 Q1 | 1 | 157 | $853.00 |